ozempic teeth: dentists warn of new glp-1 side effect and tooth decay: warning for GLP‑1 weight-loss users Ozempic Is Changing Your Teeth

Researchers often compare Retatrutide vs Tirzepatide to better understand how different receptor combinations influence experimental outcomes

Retatrutide is a next generation, once weekly weight loss injection that acts on three hormone pathways at once, which is why it is being called a triple agonist

The Phase 2 trial data suggests retatrutide produces greater weight loss than either semaglutide or tirzepatide at comparable timepoints

Reduced hunger is expected

Learn more Dual GIP/GLP-1 receptor agonist with the highest average weight loss of any approved anti-obesity medication

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have ushered in a new era of diabetes management and weight loss, with some estimates suggesting 1 in 8 Americans could be taking these jabs